Abstract:Down syndrome (DS; trisomy 21) is one of the most common genetic causes of intellectual disability, which is attributed to triplication of genes located on chromosome 21. Elevated levels of several microRNAs (miRNAs) located on chromosome 21 have been reported in human DS heart and brain tissues. The Ts65Dn mouse model is the most investigated DS model with a triplicated segment of mouse chromosome 16 harboring genes orthologous to those on human chromosome 21. Using ABI TaqMan miRNA arrays, we found a set of miRNAs that were significantly up- or downregulated in the Ts65Dn hippocampus compared to euploid controls. Furthermore, miR-155 and miR-802 showed significant overexpression in the Ts65Dn hippocampus, thereby confirming results of previous studies. Interestingly, miR-155 and miR-802 were also overexpressed in the Ts65Dn whole blood but not in lung tissue. We also found overexpression of the miR-155 precursors, pri- and pre-miR-155 derived from the miR-155 host gene, known as B cell integration cluster, suggesting enhanced biogenesis of miR-155. Bioinformatic analysis revealed that neurodevelopment, differentiation of neuroglia, apoptosis, cell cycle, and signaling pathways including ERK/MAPK, protein kinase C, phosphatidylinositol 3-kinase, m-TOR and calcium signaling are likely targets of these miRNAs. We selected some of these potential gene targets and found downregulation of mRNA encoding Ship1, Mecp2 and Ezh2 in Ts65Dn hippocampus. Interestingly, the miR-155 target gene Ship1 (inositol phosphatase) was also downregulated in Ts65Dn whole blood but not in lung tissue. Our findings provide insights into miRNA-mediated gene regulation in Ts65Dn mice and their potential contribution to impaired hippocampal synaptic plasticity and neurogenesis, as well as hemopoietic abnormalities observed in DS.

Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children

Genome-wide expression analysis in Down syndrome: insight into immunodeficiency

Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics

Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome

Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers

The immunoreactive signature of monocyte-derived dendritic cells from patients with Down syndrome

Aberrations in Circulating Inflammatory Cytokine Levels in Patients with Down Syndrome: a Meta-Analysis

Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.

Single‐cell landscape analysis reveals systematic senescence in mammalian Down syndrome

Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination

Exosomal biomarkers in Down syndrome and Alzheimer's disease

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions

The burden of trisomy 21 disrupts the proteostasis network in Down syndrome

Single-cell multi-omics map of human fetal blood in Down syndrome

Accelerated epigenetic aging in Down syndrome

Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21

Abnormal MicroRNA Expression in Ts65Dn Hippocampus and Whole Blood: Contributions to Down Syndrome Phenotypes

Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells

Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer's Disease